豪爾賽(002963.SZ):2024年度預虧1.25億元-1.78億元
格隆匯1月24日丨豪爾賽(002963.SZ)公佈2024年度業績預吿,2024年歸屬於上市公司股東的淨利潤虧損1.25億元-1.78億元,同比盈轉虧;扣除非經常性損益後的淨利潤虧損6,856.45萬元-12,203.48萬元;基本每股收益虧損0.83元/股-1.19元/股。
鑑於行業景氣度的降低以及市場競爭的加劇,照明工程項目的毛利率相較於上年同期有所下降;公司對投資項目進行了評估,並對部分投資項目計提了減值準備;回款延期導致資產及信用減值準備增加,綜合以上因素導致公司盈利能力下降,本年度業績出現虧損。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.